Navigation Links
Genedata Screener Extends Support for High-Throughput Thermofluor Assays
Date:9/3/2013

must enable fast and accurate processing of melting curves without time-consuming manual reviews. Genedata Screener uniquely provides these capabilities for TSA in high-throughput mode.

Genedata Screener helps pharmaceutical companies realize the full value of label-free technologies such as TSA. It has been shown to effectively eliminate time-consuming and inaccurate manual processes by automatically processing and synoptically compiling results. Specific quality metrics highlight curves requiring review and direct visual access to curves enables instantaneous curve analysis. Its flexible and accurate data analysis platform can scale from the smallest datasets to thousands of plates in 96-, 384- and 1536-well formats with full time/temperature resolution. In TSA/DSF experiments, Genedata Screener visualization capabilities help to optimize the temperature window by enabling scientists to review overlays of hundreds of melting curves.

Genedata Screener provides a single platform for capturing, analyzing, and managing all types of screening data. It reduces data processing times by upwards to 80% and integrates with any plate-based instrument to support screening at all throughputs, as well as High Content-, Ion Channel-, and Label-free screening technologies. Genedata Screener also allows detailed analyses of cell sub-population changes and compound synergy effects, giving researchers a standardized platform on which they can efficiently visualize and explore compound combinations at unprecedented processing speed and with unsurpassed result quality.

“More than half of the top 25 pharmaceutical companies already rely on Genedata Screener to support a wide variety of plate-based screening technologies, making it the platform of choice for all types of screening data analysis,” said Dr. Othmar Pfannes, CEO of Genedata. “With
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Genedata at ESACT Announces Expansion Into Biopharma Process Development
2. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
3. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
4. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
5. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
6. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
7. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
8. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
9. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
10. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
11. Genedata Screener for HCS Advances Phenotypic Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... Europe and the United States and plenary talks by ... for SPIE Optics + Optoelectronics next month ... 700 technical presentations in 17 conferences alongside a two-day ... optics and photonics , the event will run 13-16 ...
(Date:3/30/2015)... Wis. , March 30, 2015  FUJIFILM Holdings ... and Cellular Dynamics International, Inc. (CEO: Robert J. ... developer and manufacturer of fully functioning human cells in ... two companies have entered into a definitive agreement whereby ... to be followed by a second step merger. Fujifilm ...
(Date:3/29/2015)... As a symbol of its commitment to ... manufacturing clients, Whitehouse Laboratories is excited to announce that ... Team for the 2015 race season. Success on the ... strong sense of precision and attention to detail. These ... the quality control testing laboratory. Sponsorship of the race ...
(Date:3/27/2015)...  Neogen Corporation (NASDAQ: NEOG ) announced today ... plan in accordance with Securities and Exchange Commission rule ... Neogen Corporation, is a minority owner of this entity ... Herbert does not have control of this entity, ... only for a portion of the shares owned by ...
Breaking Biology Technology:Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2Neogen CEO adopts 10b5-1 Trading Plan 2
... and LUND, Sweden, February 23 , ... Partial Factor VIII Inhibition in,Patients Undergoing Knee Replacement Surgery ... THR) and co-development partner,BioInvent International (OMXS: BINV) announce today ... II trial with their long-acting anticoagulant,TB-402 for the prophylaxis ...
... SANTA MONICA, Calif., Feb. 20 Cord Blood ... cord blood stem cell preservation company ( http://www.cordblood-america.com ... of stem cells to families nationwide and internationally, ... in an interview with analyst Francis Gaskins, provided ...
... Natural and Organic,Cosmetic* products are now identifiable at ... 100 products have already been certified as of ... NaTrue-Label provides orientation for consumers and manufacturers,alike by ... Organic,Cosmetics. It is international, not for profit, open ...
Cached Biology Technology:ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 2ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 3ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 4ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 5In Analyst Interview, Cord Blood America Provides Details of Special Shareholder Meeting 2NaTrue-Label: The First 100 Products are Certified 2
(Date:3/19/2015)... March 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, announces its biometric payment ... clip that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host ... way to pay, and ,a really big breakthrough in mobile ...
(Date:3/17/2015)... 17, 2015 Emotient, the leader in ... announced general availability of Emotient Analytics , ... analysis of facial expressions. The system analyzes videos ... products and services. It delivers audience response metrics ... - as derived from facial evidence of emotional ...
(Date:3/12/2015)... 12, 2015 IriTech, a leading iris based ... the Texas Instruments Design Network, announced today that the ... its IriShield USB MK2120U device during a launching event ... distribution. The iris scanner is manufactured ... in India through its Indian ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3
... (NAS) and Institute of Medicine (IOM) today released SCIENCE, ... public a comprehensive and up-to-date picture of the current ... science classroom. Recent advances in science and medicine, ... the past 150 years, have reinforced evolution,s role as ...
... the latest American Chemical Society (ACS) News Service Weekly PressPac ... Engineering News.,Please credit the individual journal or the American Chemical ... IS FOR IMMEDIATE USE EXCEPT ARTICLE #5, which is embargoed ... ARTICLE #1 FOR IMMEDIATE RELEASE ...
... researchers have uncovered a critical difference between flu viruses that ... monitor the evolution of avian flu strains and aid in ... The researchers found that a virus,s ability to infect humans ... of receptor on the surface of human respiratory cells. ...
Cached Biology News:Scientific evidence supporting evolution continues to grow 2Scientific evidence supporting evolution continues to grow 3American Chemical Society's weekly PressPac -- Jan. 2, 2008 2American Chemical Society's weekly PressPac -- Jan. 2, 2008 3American Chemical Society's weekly PressPac -- Jan. 2, 2008 4American Chemical Society's weekly PressPac -- Jan. 2, 2008 5American Chemical Society's weekly PressPac -- Jan. 2, 2008 6American Chemical Society's weekly PressPac -- Jan. 2, 2008 7American Chemical Society's weekly PressPac -- Jan. 2, 2008 8American Chemical Society's weekly PressPac -- Jan. 2, 2008 9MIT finds key to avian flu in humans 2MIT finds key to avian flu in humans 3